Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | WRN | Q14191 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.31 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.31 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL6300410 | 0.82 | NAAA (0.34) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL6300411 | 0.74 | — | — | |
| SCHEMBL9818993 | 0.72 | NAAA (0.39) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL14191352 | 0.72 | TSHR (0.52) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL3628331 | 0.72 | TSHR (0.52) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL31187667 | 0.71 | NAAA (0.38) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL2877928 | 0.71 | ALDH1A1 (0.38) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL20236977 | 0.71 | LMNA (0.38) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL22721833 | 0.71 | ALDH1A1 (0.42) | NAAAALDH1A1LMNACYP3A4TSHR | |
| SCHEMBL28987904 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230043518-A1 | CANCER IMMUNOTHERAPY | Axelia Oncology Pty Ltd (AU) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043518-A1 | CANCER IMMUNOTHERAPY | TLR2, CD274, PDCD1LG2 | NAAA 1757/4885ALDH1A1 1771/4885LMNA 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.